(no title)
benchtobedside | 1 year ago
The biggest difference was seen when comparing patients who took semaglutide to those who took insulin: Semaglutide patients had a 70% lower risk of Alzheimer’s, the study found.
Full link to the study itself: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz...
Someone1234|1 year ago
nordsieck|1 year ago
So far, I haven't seen much evidence that GLP-1s have a positive effect on people who aren't overweight. And while I'll be the first to admit that the proportion of people who could benefit from these drugs is quite large, it's pretty far from everyone.
unknown|1 year ago
[deleted]
thefz|1 year ago
AStonesThrow|1 year ago
SoftTalker|1 year ago
BJones12|1 year ago